Key facts
- No Barrier AI’s last known valuation is $10.0M (Sep 2025).
- It has raised $3.1M; the latest was Seed Round ($2.7M) in Sep 2025.
- Notable investors include Arkin Capital, Esplanade Healthtech Ventures, Fusion VC, Rock Health Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for No Barrier AI
- ·The full record, as it builds
Funding rounds
No funding rounds for No Barrier AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About No Barrier AI
Developer of an AI medical interpreter technology designed to remove language barriers. The company's technology controls the medical jargon and provides interpretation services similar to professional interpreters while considering age, gender, and language formality factors, enabling the healthcare industry to make encounters with Limited English Proficiency (LEP) patients accurate and affordable.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2023
- Employees
- 8
- Website
- nobarrier.ai/
- Ownership
- Privately Held (backing)
No Barrier AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in No Barrier AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on No Barrier AI in its N-PORT filings yet. We sweep new filings monthly.